Methicillin-resistant Staphylococcus aureus (MRSA), a notorious superbug responsible for severe infections worldwide, poses a growing challenge in the United Arab Emirates. Recent research led by scientists affiliated with Khalifa University has shed new light on the molecular differences between invasive and non-invasive strains of this pathogen. By employing cutting-edge proteomic and metabolomic profiling techniques, the study identifies potential biomarkers that could revolutionize how clinicians predict and manage MRSA infections.
This breakthrough, published in Frontiers in Microbiology, underscores the pivotal role of UAE higher education institutions in tackling antimicrobial resistance (AMR), a priority area aligned with national health strategies. As MRSA rates climb in the region—from 21.9% of Staphylococcus aureus isolates in 2010 to 33.5% in 2021—such insights are timely and critical for public health.
Unraveling the Threat of MRSA in the UAE Context
Staphylococcus aureus is a common bacterium found on skin and in noses, but when it becomes methicillin-resistant (MRSA), it evades beta-lactam antibiotics like methicillin, penicillin, and oxacillin. This resistance arises primarily from the mecA gene, encoding penicillin-binding protein 2a (PBP2a), which alters cell wall synthesis.
In the UAE, surveillance data reveals a rising burden. National efforts, including the UAE National Action Plan on Antimicrobial Resistance 2025-2031, emphasize surveillance, stewardship, and research to curb this trend. Hospitals report MRSA in bloodstream infections, skin and soft tissue infections, and even retail meats, highlighting transmission risks across human-animal-environment interfaces.
Khalifa University, a leader in UAE biomedical research, contributes through its Department of Biological Sciences and collaborations like the UAE-UK One Health AMR Biosecurity Consortium. This consortium fosters genomic surveillance and innovative solutions to combat AMR.
The Innovative Dual-Extraction Method Pioneered by the Team
The study utilized a dual-functionality methanol extraction protocol to simultaneously isolate proteins and metabolites from MRSA samples—a method validated in prior work by the same group comparing MRSA and methicillin-sensitive S. aureus (MSSA). This approach, using methanol's biphasic properties, streamlines analysis, reducing time and sample needs.
Isolates included 23 invasive MRSA from blood cultures, 49 from superficial skin infections, and 24 nasal colonizers. Proteomics employed Orbitrap Exploris 480 mass spectrometry with data-independent acquisition (DIA), processed via DIA-NN, identifying 2,000 proteins. Metabolomics used TimsTOF with MetaboScape, detecting 150 metabolites.
Proteomic Signatures: Proteins Driving Invasiveness
Proteomic analysis pinpointed staphylococcal secretory antigen SsaA2 as significantly elevated in invasive MRSA. SsaA2, part of the Ess secretion pathway, aids in immune evasion and virulence, potentially enhancing bloodstream survival.
Conversely, invasive strains showed reduced levels of small ribosomal subunit protein bS20, involved in translation, and bifunctional autolysin, which regulates cell wall turnover. Lower autolysin may stiffen cell walls, resisting host defenses and antibiotics. These shifts suggest metabolic reprogramming for persistence in harsh environments like blood.
Enrichment analysis linked these proteins to fatty acid metabolism, beta-lactam resistance, and stress responses, echoing findings from the team's 2024 MRSA-MSSA study where 407 differentially expressed proteins highlighted similar pathways.
Photo by Jake De-bique on Unsplash
Metabolomic Insights: Metabolites Marking Pathogenic Potential
Metabolomics revealed elevated sphinganine and phosphoserine in invasive isolates. Sphinganine, a sphingolipid precursor, bolsters membrane integrity against host antimicrobials. Phosphoserine supports protein phosphorylation, crucial for signaling in infection.
Reduced metabolites included cytidine (nucleoside for RNA), benzoic acid (antimicrobial preservative), and guanosine (purine nucleoside). These depletions indicate nucleotide starvation or efflux, aiding survival. Arginine biosynthesis pathways were enriched, fueling polyamine production for stress tolerance.
Such profiles offer a metabolic fingerprint for rapid invasive MRSA detection, potentially via point-of-care mass spec.
Spotlight on Lead Researcher Syrine Boucherabine and Khalifa University
Syrine Boucherabine, a post-doctoral fellow at Khalifa University's Department of Biological Sciences and PhD from MBRU, spearheaded this work. Her prior awards, like first place at the Emirates Society of Clinical Microbiology conference, highlight her expertise in MRSA molecular epidemiology.
Collaborators include Abiola Senok, MBRU Chair of Basic Medical Sciences, and Nelson da Cruz Soares, proteomics expert. Khalifa University's Infection Research Unit drives AMR genomics, aligning with UAE's Vision 2031 for health innovation.
The university's state-of-the-art facilities, like advanced mass spectrometers, enable such high-impact research, positioning KU as a hub for translational microbiology in the Gulf.
Clinical and Public Health Implications for the UAE
Identifying SsaA2, sphinganine, and others as biomarkers could enable quick triage: high-risk patients prioritized for aggressive therapy, reducing mortality. In UAE hospitals, where MRSA bloodstream prevalence nears 35%, this matters.
Therapeutically, targeting sphingolipid pathways or autolysin inhibitors might sensitize invasive strains. For surveillance, these markers enhance genomic tracking under UAE's GLASS-aligned system.Read the full study here.
The research supports UAE's AMR Action Plan, promoting One Health integration and R&D investment.
Broader Contributions to Global AMR Research
Building on global proteomics in MRSA tolerance, this UAE-led work advances biomarker discovery amid WHO's priority pathogen list. Similar studies show proteomic shifts in evolved resistant strains, but clinical invasiveness profiling is novel.
Future Directions and Opportunities at UAE Universities
Next steps include validating biomarkers in larger cohorts and developing assays. Khalifa University eyes AI integration for multi-omics prediction, fostering PhD programs in AMR.KU's AMR surveillance contributions.
For aspiring researchers, UAE institutions offer robust funding via NAP 2025-2031, emphasizing innovation.
Conclusion: Pioneering Solutions from UAE Academia
This Khalifa University-affiliated study exemplifies how UAE higher education drives AMR solutions. By decoding MRSA's molecular secrets, it paves the way for smarter diagnostics and therapies, safeguarding public health in a high-prevalence region.
